Recent changes

Favicon for www.priv.gc.ca

Global Data Protection Authorities Statement on AI Imagery Privacy

Sixty global data protection and privacy authorities have issued a joint statement outlining privacy principles for AI-generated imagery. The statement calls on organizations developing and using AI content generation systems to implement safeguards and protect individuals, particularly children, from potential harm.

Priority review Guidance Data Privacy
Favicon for www.priv.gc.ca

Privacy Commissioner Recommends Bill C-4 Amendments for Political Party Privacy

The Privacy Commissioner of Canada recommended amendments to Bill C-4 to introduce privacy rules for political parties. The Commissioner suggested that these rules should parallel existing public and private sector requirements under federal law, adapted for the democratic context.

Priority review Notice Data Privacy
Favicon for www.priv.gc.ca

Privacy Commissioner of Canada ArriveCAN App Investigation Report

The Privacy Commissioner of Canada has tabled a special report on the ArriveCAN app investigation. While no contraventions of the Privacy Act were found, the report outlines steps the Canada Border Services Agency must take to strengthen privacy and security in its contracting framework.

Routine Notice Healthcare
Favicon for www.albertasecurities.com

ASC Investor Alert: BG Wealth Sharing Suspected Investment Scheme

The Alberta Securities Commission (ASC) has issued an investor alert warning the public about BG Wealth Sharing, a suspected investment scheme promoted via social media and messaging apps. The scheme, linked to DSJ Exchange, claims to use AI for guaranteed returns and is not registered in Alberta.

Priority review Enforcement Securities
Favicon for www.albertasecurities.com

CSA Disarms Over 7,500 Fraudulent Investment Websites

Canadian securities regulators have announced the successful deactivation of over 7,500 fraudulent investment and crypto scam websites between June 2025 and February 2026. This initiative, highlighted during Fraud Prevention Month, aims to protect investors from online scams.

Priority review Notice Securities
Favicon for www.albertasecurities.com

ASC Alleges Securities Law Breaches by Daniel Astete and 2307755 Alberta Ltd

The Alberta Securities Commission (ASC) has issued a Notice of Hearing alleging that Daniel Rodolfo Astete and 2307755 Alberta Ltd. breached Alberta securities laws by engaging in illegal distributions of securities. The companies allegedly raised approximately $500,000 through a crowdfunding platform without filing a prospectus, and improperly paid $21,000 to Astete from the funds raised.

Priority review Enforcement Securities
Favicon for www.albertasecurities.com

Securities Regulators Amend Benchmark Assurance Report Requirements

Canadian securities regulators have adopted final amendments to Multilateral Instrument 25-102, strengthening assurance report requirements for designated benchmarks. These changes clarify the scope, timing, and level of assurance for reports submitted by independent public accountants, effective May 5, 2026.

Priority review Rule Securities
Favicon for www.albertasecurities.com

Court Dismisses Ronald Aitkens' Appeal of Fraud Conviction

The Alberta Securities Commission (ASC) announced that the Court of King's Bench dismissed Ronald Aitkens' appeal of his 2024 conviction and sentence for fraud and making false or misleading statements. The appeal related to securities distributed through an offering memorandum for Legacy Communities Inc.

Priority review Enforcement Securities
Favicon for www.canada.ca

Health Canada Implements ICH Pharmaceutical Guidelines

Health Canada is implementing new International Council for Harmonisation (ICH) guidelines for pharmaceuticals, including M13A and Q12/Q14. These implemented ICH guidelines will take precedence over existing Health Canada guidance documents where discrepancies exist, potentially leading to amendments or withdrawals of current guidance.

Priority review Guidance Pharmaceuticals
Favicon for www.canada.ca

Health Canada Implements ICH Q12 and Q14 Guidance

Health Canada has announced the implementation of International Council for Harmonisation (ICH) Q12 and Q14 guidance. The initial scope focuses on Post Approval Change Management Protocols (PACMPs) for Biologic and Radiopharmaceutical Drugs Directorate products, with further implementation details to follow.

Priority review Notice Pharmaceuticals

Showing 91–100 of 221 changes

1 8 9 10 11 12 23

Get Canada alerts

Daily digest of regulatory changes. AI-summarized, no noise.

Free. Unsubscribe anytime.